1. Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study. Issue 9 (29th July 2019) Authors: Horvath, Noemi; Spencer, Andrew; Kenealy, Melita; Joshua, Douglas; Campbell, Philip J; Lee, Je-Jung; Hou, Jian; Qiu, Lugui; Kalff, Anna; Khong, Tiffany; Londhe, Anil; Siggins, Sarah; van Kooten Losio, Maximiliano; Eisbacher, Michael; Prince, H. Miles Journal: Leukemia & lymphoma Issue: Volume 60:Issue 9(2019) Page Start: 2122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗